|
May 1
|
United Therapeutics Corporation Reports First Quarter 2024 Financial Results
|
|
Apr 29
|
What Makes United Therapeutics (UTHR) a New Buy Stock
|
|
Apr 25
|
Stevanato Group (STVN) to Report Q1 Results: What You Should Expect
|
|
Apr 24
|
United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?
|
|
Apr 24
|
United Therapeutics Announces World’s First Successful Xenothymokidney Transplant
|
|
Apr 24
|
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
|
|
Apr 16
|
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference
|
|
Apr 10
|
Innovation in Healthcare: HTEC’s Q1 2024 Index Rebalance
|
|
Apr 6
|
Insider Sell: Chairperson & CEO Martine Rothblatt Sells 30,000 Shares of United ...
|
|
Apr 4
|
3 Underappreciated Healthcare Stocks to Buy Now: April 2024
|
|
Mar 29
|
United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 29,125 Shares
|
|
Mar 29
|
Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report?
|
|
Mar 28
|
Why Is Esperion Therapeutics (ESPR) Up 2% Since Last Earnings Report?
|
|
Mar 27
|
United Therapeutics Corp (UTHR) CEO Martine Rothblatt Sells 30,000 Shares
|
|
Mar 26
|
United Therapeutics' Robust Portfolio Fuels Double-Digit Growth
|
|
Mar 26
|
United Therapeutics Announces the First Comprehensive Review Publication on Xenotransplantation
|
|
Mar 25
|
Insider Sell: United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells ...
|
|
Mar 25
|
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
|
|
Mar 22
|
Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?
|
|
Mar 21
|
United Therapeutics Corp (UTHR) Chairperson & CEO Martine Rothblatt Sells 30,000 Shares
|